Neoadjuvant 90 Yttrium peptide receptor radionuclide therapy for advanced rectal neuroendocrine tumour: a case report.

Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/256

Title:	Neoadjuvant 90 Yttrium peptide receptor radionuclide therapy for advanced rectal neuroendocrine tumour: a case report.
Epworth Authors:	Ryan, Jennifer Lynch, A. Craig Heriot, Alexander
Other Authors:	Akhurst, Timothy Michael, Michael
Keywords:	Department of Surgery, Epworth Healthcare, Melbourne, Victoria, Australia Cancer Services Colonoscopy WHO (World Health Organization) Neuroendocrine Tumour Rectal Cancer Radiation Oncology
Issue Date:	Oct-2014
Publisher:	Wiley
Citation:	Article in Press 2014
Abstract:	A 53-year-old man presented with a 2-year history of constipation and tenesmus. Colonoscopy performed in January 2012, diagnosed a large fungating tumour in the lower rectum 7–8 cm from the anal verge. Biopsies confirmed a World Health Organization (WHO) grade 2 or intermediate grade neuroendocrine tumour (NET) of L-cell type (Ki67 index of 3–4%).
URI:	http://hdl.handle.net/11434/256
DOI:	10.1111/ans.12854
PubMed URL:	http://www.ncbi.nlm.nih.gov/pubmed/25307828
ISSN:	1445-2197
Journal Title:	ANZ Journal of Surgery
Type:	Journal Article
Affiliated Organisations:	Department of Cancer Surgery, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Type of Clinical Study or Trial:	Case Series and Case Reports
Appears in Collections:	Cancer Services Radiation Oncology

Files in This Item:

There are no files associated with this item.